Anzeige
Meldung des Tages: Breaking News: TeaRx™ erobert Großbritannien im Sturm?!

West Pharmaceutical Services Aktie News

Aktie
WKN:  864330 ISIN:  US9553061055 US-Symbol:  WST Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
204,55 €
-0,15 €
-0,07%
11:58:03 Uhr
Depot/Watchlist
Marktkapitalisierung *
16,76 Mrd. €
Streubesitz
1,58%
KGV
48,96
Dividende
0,85 $
Dividendenrendite
0,31%
Nachhaltigkeits-Score
32 %
Index-Zuordnung
S&P 500

West Pharmaceutical Services News

17.02.26 - PR Newswire
West Announces Quarterly Dividend and Share Repurchase Program
West Announces Quarterly Dividend and Share Repurchase Program PR Newswire
14.02.26 - wallstreetONLINE Redaktion
Community Rückblick: "...strategisch wird jetzt das Tafelsilber geopfert, um die Bilanz zu retten."
Die Gerresheimer Aktie crashte am 11. Februar erneut, nachdem eine Verschiebung des Jahresabschlusses 2025 und der Verkauf der US Tochter "Centor Inc." angekündigt ...
12.02.26 - PR Newswire
West Reports Fourth-Quarter and Full-Year 2025 Results
West Reports Fourth-​Quarter and Full-Year 2025 Results PR Newswire
29.01.26 - PR Newswire
West to Host Fourth-Quarter and Full-Year 2025 Conference Call
West to Host Fourth-​Quarter and Full-Year 2025 Conference Call PR Newswire
20.01.26 - PR Newswire
West Synchrony™ S1 Prefillable Syringe System Commercially Available at Pharmapack
West Synchrony™ S1 Prefillable Syringe System Commercially Available at Pharmapack PR Newswire
12.01.26 - PR Newswire
AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the United States
AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the United States PR Newswire
12.01.26 - PR Newswire
West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie
West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie PR Newswire
12.12.25 - PR Newswire
West to Participate in Upcoming Investor Conference
West to Participate in Upcoming Investor Conference PR Newswire
10.12.25 - PR Newswire
West Declares Quarterly Dividend
West Declares Quarterly Dividend PR Newswire
27.10.25 - PR Newswire
West Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery
West Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-​level solution for drug delivery PR Newswire
24.10.25 - PR Newswire
West to Participate in Upcoming Investor Conferences
West to Participate in Upcoming Investor Conferences PR Newswire
23.10.25 - PR Newswire
West Reports Third-Quarter 2025 Results
West Reports Third-​Quarter 2025 Results PR Newswire
18.10.25 - wallstreetONLINE Redaktion
Community Rückblick: "Ich hab das Bedürfnis dort morgen hinzufahren und komplett auszurasten"
Die Gerresheimer Aktie crashte in der letzten Woche erneut, nachdem eine Absenkung der Jahres­prognose bekanntgeben wurde. Die Investierten innerhalb der wO-​Community ...
09.10.25 - PR Newswire
West to Host Third-Quarter 2025 Conference Call
West to Host Third-​Quarter 2025 Conference Call PR Newswire
21.08.25 - PR Newswire
West to Participate in Upcoming Investor Conferences in September 2025
West to Participate in Upcoming Investor Conferences in September 2025 PR Newswire
24.07.25 - PR Newswire
West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance
West Announces Second-​Quarter 2025 Results and Fourth-​Quarter 2025 Dividend, Updates Full-Year 2025 Guidance PR Newswire
21.07.25 - PR Newswire
West Welcomes Robert McMahon as Incoming Chief Financial Officer
West Welcomes Robert McMahon as Incoming Chief Financial Officer PR Newswire
08.07.25 - PR Newswire
West to Host Second-Quarter 2025 Conference Call
West to Host Second-​Quarter 2025 Conference Call PR Newswire
07.07.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming ...
07.07.25 - PR Newswire
WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit with the Schall Law Firm
WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire

Newssuche

Videos

newspaper
18.02.26 -2,76%
Technical Trading: Chance mit 82 Prozent Treffern
Rohöl Long Typ: Turbo Open End WKN: VH65XQ Hebel:6 Laufzeit: OpenEnd Einstieg: Market ... Mehr »
Anzeige

Aktie im Fokus

Breaking News
DiagnosTear Technologies Inc
0,268 €
+5,51%
DiagnosTear Technologies Inc Chart
TeaRx™ erobert Großbritannien im Sturm?!
Mehr zur Aktie »